BioWorld MedTech

Feb. 19, 2019

FDA establishes new interoperable insulin pump device class – with Tandem up first

Tandem Diabetes Care Inc. saw its shares climb almost 20 percent this week, just as it became the first company to have a product classified in a new FDA category: Alternate Controller Enabled Infusion Pumps (ACE pumps). Read More

IBM shines at HIMSS with news of collaborations

Advisory panel says mesh should be superior to repair out to 36 months

India includes more med tech under existing law as it gears up for new framework

US, UK ink deal that protects trade regardless of Brexit outcome

Holiday notice

Appointments and advancements

Financings

Regulatory front

BioWorld MedTech stock report for public med-tech companies

Product briefs

Other news to note

BioWorld MedTech's Cardiology Extra

Today's news in brief

BioWorld

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...

VST Bio’s VB-001 is neuroprotector after stroke

BioWorld Science

At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...